Drug Trial Radar · NCT03174236
First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition
Last checked: Nov 19, 2026Latest source record: May 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,000
Planned (sponsor's estimate)
Start
Sep 4, 2017
Primary completion
Jan 31, 2020
Study completion Dec 31, 2020
Sponsor
- Lead sponsor
- University of OxfordAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University College, London; London School of Hygiene and Tropical Medicine; Swansea Trials Unit; Kenya Medical Research Institute; KEMRI-Wellcome Trust Collaborative Research Program
- First posted
- Jun 2, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 months, up to 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Children with severe malnutrition who are admitted sick to hospitals have a high mortality(death rate), usually because of infection. All children with severe malnutrition admitted to hospitals are treated with antibiotics(medication used to kill bacteria). However, the current antibiotics used in hospitals may not be the most effective. It is possible that the antibiotics that are currently used after initial antibiotics should be used first. No studies have been carried out to determine if the current antibiotics used for treating malnourished children who are sick and admitted in hospital are the most appropriate. The aim of this study is to find out if a changed antibiotic system for children with malnutrition is safe, reduces the risk of death and improves nutritional recovery.
Conditions
- Malnutrition Severe
- Antibiotic Resistance
- Antibiotic Toxicity
Interventions
CeftriaxoneDrug
Ceftriaxone a third-generation cephalosporin. Ceftriaxone is active against a broad spectrum of Gram positive and Gram negative bacteria.
Benzyl penicillinDrug
The currently recommended first-line antibiotics for the treatment of severe acute malnutrition are gentamicin plus ampicillin or penicillin.
MetronidazoleDrug
The WHO guidelines recommend that Metronidazole may be given in addition to broad-spectrum antibiotics, "however, the efficacy of this treatment has not been established in clinical trials."
PlaceboOther
Suspension manufactured to match metronidazole
GentamicinDrug
The currently recommended first-line antibiotics for the treatment of severe acute malnutrition are gentamicin plus ampicillin or penicillin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: 90 days after enrolment.
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
KEMRI WT Clinical Trials Facility
Kilifi, Kenya
Kilifi County Hospital
Kilifi, Kenya
Coast General Hospital - Study site
Mombasa, Kenya
Mbagathi District Hospital
Nairobi, Kenya
Mbagathi Hospital
Nairobi, Kenya
Kilifi County Hospital
Kilifi, Coast, Kenya
Kemri Wellcome Trust Research Programme
Kilifi, Coast Province, Kenya
Mbale Regional Referral Hospital
Mbale, Uganda
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.